Skip to main content
. 2002 Aug;70(8):4638–4642. doi: 10.1128/IAI.70.8.4638-4642.2002

TABLE 1.

Clinical and immunohistological data for the analyzed LCL and DCL skin biopsies

Group Patient no. (age [yr]) Clinical diagnosis No. of lesions (age of biopsied lesion[s]) Histological and parasitological diagnosisa Parasites/field (×100)b No. of iNOS-positive cells (mean ± SD)/field (×100)
I 1 (34) LCL 1 (5 yr) LCL 4.0 ± 2.0 81 ± 17
2 (30) LCL 2 (4 mo) LCL 2.3 ± 0.7 20 ± 2
3 (15) LCL 6 (1 mo) LCL 21.0 ± 9.3 25 ± 8
4 (30) LCL 1 (2 mo) LCL 26.0 ± 1.7 32 ± 4.6
5 (34) LCL 1 (?)c LCL 30.0 ± 9.3 8 ± 6.0
6 (41) LCL 1 (?) LCL 28.0 ± 8.3 36 ± 11
7 (28) LCL 1 (2 mo) LCL 1.2 ± 1.1 56 ± 14
8 (28) LCL 2 (2 mo) LCL 5.0 ± 1.6 11 ± 6.3
9 (91) LCL 1 (?) LCL 38 ± 8.5 13 ± 6.5
II 10 (25) LCL 1 (1 mo) Similar to LCL ca. 2-3% 19 ± 11.7
11 (16) LCL 1 (5 mo) Similar to LCL ca. 30% 14 ± 8.8
12 (43) LCL 2 (1.5 mo) Similar to LCL ca. 50-70% 3 ± 0.6
13 (68) LCL 1 (5 mo) Similar to LCL ca. 60% 4 ± 4.2
III 14 (40) DCL Multiple (2 mo) DCL ca. 100% 6 ± 1.9
15 (40) DCL Multiple (2 mo) DCL ca. 100% 7 ± 4.5
16 (53) DCL Multiple (3 mo) DCL ca. 100% 7 ± 2.4
17 (18) DCL Multiple (5 mo) DCL ca. 50% 18 ± 5.4
a

Clinically and histopathologically (as assessed by H&E staining; see Material and Methods), the lesions of group II patients did not differ from those of group I patients except for the presence of a high number of parasites (which was otherwise seen only in DCL lesions).

b

For group I patients, clusters of Leishmania parasites per section were determined because individual parasites could not be counted. Numbers of parasites per field are given as means ± standard deviations. For group II and III patients, neither individual parasites nor clusters of parasites could be determined due to the extremely high parasite burden. Therefore, parasite burden is given as the estimated percentage of the L. mexicana-immunostained area per section.

c

Question marks denote unknown ages.